Back

Who is at risk of cardiovascular toxicity? - discussion

20 June 2025 (11:50 - 12:00)
Organised by: Logo
Congress Presentation Part of: Guidelines in Practice: who is at risk of cardiovascular toxicity? Cardiovascular Toxicity Stratification CCO Premium Access ESC Cardio-Oncology 2025 Council of Cardio-Oncology

3 More presentations in this session

Presentation thumbnail
Risk stratification strategies in non-Hodgkin lymphoma: case presentation
Professor J. Alexandre (Caen, FR)
Slides Video
Presentation thumbnail
Risk stratification strategies in patients receiving tyrosine kinase inhibitors: case presentation
Doctor M. Mirabel (Paris, FR)
Slides Video
Presentation thumbnail
What do the ESC Guidelines on Cardio-Oncology say and how should they be implemented?
Professor J. Liu (New York, US)
Slides Video

Access the full session

Session thumbnail
Guidelines in Practice: who is at risk of cardiovascular toxicity?

The Event

Event poster

ESC Cardio-Oncology 2025

20 June 2025 11:50 CET
You may be interested in
thumbnail
Webinar
What we need to know before cancer therapy. ESC 2022 Clinical Practice Guidelines - Webinar Series
8 September 2022
thumbnail
Congress Presentation
Risk factors cardiovascular diseases in the population of young adults
14 June 2025
thumbnail
Congress Presentation
Cardiovascular risk assessment in multiple myeloma patients undergoing carfilzomib therapy: a new risk prediction model for cardiovascular adverse events
12 December 2020
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources